Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results

Last Modified: 4/11/2008 First Published: 7/26/2003


1.		Phase I/II Study of GTI-2040 and Capecitabine in Patients With Advanced or Metastatic Renal Cell Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				Pharmaceutical / Industry				LORUS-L01-1409 NCT00056173

Last Modified: 10/2/2006 First Published: 11/20/2003


2.		Phase II Study of GTI-2040 and Docetaxel in Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors (Phase I study closed to accrual as of 8/5/2004)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				PMH-PHL-017 NCI-6104, NCT00074022, 6104

Last Modified: 8/8/2007 First Published: 8/24/2003


3.		Phase II Study of GTI-2040 and Capecitabine in Patients With Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				CCC-PHII-46 UCD-200311533-1, CHNMC-PHII-46, NCI-6093, NCT00068588, 6093

Last Modified: 7/16/2007 First Published: 6/23/2004


4.		Phase II Study of GTI-2040, Docetaxel, and Prednisone in Patients With Hormone-Refractory Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				PMH-PHL-024 NCI-6102, 6102, NCT00087165

Last Modified: 11/11/2008 First Published: 9/24/2003


5.		Phase I Study of GTI-2040 and High-Dose Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				OSU-0304 OSU-20030030, NCI-6108, NCT00070551, 6108

Last Modified: 11/21/2007 First Published: 2/20/2004


6.		Phase I Study of GTI-2040 and Gemcitabine in Patients With Metastatic or Unresectable Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				CTRC-IDD-0306 NCI-6090, NCT00078962, 6090

Last Modified: 3/28/2006 First Published: 5/28/2004


7.		Phase I Study of GTI-2040, Oxaliplatin, and Capecitabine in Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				CCC-PHI-41 CHNMC-PHI-41, NCI-6099, 6099, NCT00084643

Select All on One Page